Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Consultation ARM 64 sought your views on the reclassification of pack sizes of 14 loratadine 10 mg tablets (Galpharm Non-drowsy Hayfever and Allergy Relief Tablets) from P to GSL.
A total of eight responses to the consultation were received, of which three were in favour, two did not agree with the proposal, one raised issues and two had no comment.
Copies of the responses (excluding those marked as 'in confidence') are available below.
| Professional pharmaceutical societies, individual pharmacists and other pharmaceutical bodies |
|---|
|
Yes to proposal |
|
Issues raised
|
|
No to proposal |
| Medical profession and royal colleges |
|---|
|
Yes to proposal
|
|
No comment |
| Patient groups, consumer groups, charities and members of the public |
|---|
|
Yes to proposal |
